12:00 AM
 | 
Dec 03, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Inavir laninamivir regulatory update

Daiichi submitted a regulatory application to Japan's Ministry of Health, Labor and Welfare (MHLW) to expand the label for Inavir laninamivir dry powder inhaler to include...

Read the full 109 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >